Research Nester released a report titled “Dermal Fillers Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global dermal fillers market in terms of market segmentation by ingredient, by product, by application and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
Dermal fillers are substances used for the restoration and enhancement of the facial structure in order to provide a fuller, wrinkle-free and younger appearance. The market for dermal fillers is projected to attain a significantly high market value and record a CAGR of about 8% during the forecast period, i.e., 2020-2028. The market is segmented by ingredient, by product, by application and by region.
According to the American Society of Plastic Surgeons, a total of 2,523,437 soft tissue filler procedures took place in 2018 in the United States, out of which, the number of procedures involving hyaluronic acid was the highest with 2,128,923 procedures.
On the basis of ingredient, dermal fillers market is further segmented into hyaluronic acid, calcium hydroxylapatite, collagen, poly-L lactic acid, PMMA [poly methyl methacrylate] and others. The hyaluronic acid segment is anticipated to hold a significant share in the market on account of growing demand and use of this gel-like substance as dermal fillers. Hyaluronic acid contains high water retention capacity, anti-ageing properties and is similar to the components present in the body. This makes the substance highly desirable and is this predicted to grow at a high rate in future.
Based on geography, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Dermal fillers are estimated to observe a rising demand in North America in order to improve facial parts for aesthetic purposes. As a result of this, the market in this region is predicted to hold the largest share over the forecast period. The market in Asia Pacific is anticipated to grow at the highest rate in the coming years. This can be attributed to the growing demand for dermal fillers for various medical dermal treatments such as scar removal and others.
Emerging Medical Institutions for Skin Treatments to Drive the Market Growth
In the past few years, the emergence of government and privately-held hospitals, clinics and other medical facilities exclusively providing dermatology treatments, including dermal fillers, is anticipated to become a key factor resulting in the market growth. However, the high costs associated with such treatments restricts a large section of the population from spending on them, which is estimated to hinder the market growth by 2028.
This report also provides the existing competitive scenario of some of the key players of the global dermal fillers market which includes company profiling of Allergan (NYSE: AGN), Merz Pharma, Sinclair Pharma, Galderma Laboratories, BioPlus Co., Ltd., Candela Corporation, BIOXIS pharmaceuticals, Suneva Medical, SCULPT Luxury Dermal Fillers Ltd and Dr. Korman Laboratories Ltd. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global dermal fillers market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
